| Enzymotec AMIET technological platform offers an alternative to more costly and environmentally unfriendly chemical and organic synthesis. Also, enables the use of enzymes in hydrophobic environments and protec |
| Genencor Offers products for the health care, agriculture and industrial chemicals markets. Includes outline of expertise, and facilities for production, administration, research and development in four contin |
| Genomics_Collaborative,_Inc_ Apply the science of human genetics to drug and diagnostic discovery decisions. Maintains a database of DNA, sera, and tissue samples, linked to clinical information from patients worldwide. |
| Genomics_One_Corporation Focuses on the development of technology platforms for genomic manipulations and gene discovery. Based in Canada. |
| Genotypic_Technology_Pvt_Ltd_ Solutions for drug discovery and research and development for pharma, genomics & biotechnology companies. Site includes details of services and current research projects. |
| Genzyme_Transgenics_Corporation Produces recombinant proteins and monoclonal antibodies for pharmaceutical use in the milk of transgenic animals. |
| Hematech Developing platform technology for the production of human polyclonal antibodies. Site features details of technology, publications and news sections. |
| In_the_Pipeline A weblog about science, particularly chemistry and pharmaceuticals, from a working researcher at a drug company. |
| Innovative_Research,_Inc_ Provides researchers worldwide with high quality human and animal plasma for research use. |
| Integrin_Advanced_Biosystems Marine biotechnology company focused on three areas: research, technology transfer and scientific services. |
| International_Biotechnology_Trust_(IBT) The UK's first approved investment trust dedicated to the biotechnology sector. It offers investors the means to invest in a carefully selected and diversified portfolio of biotechnology companies. As |
| Knowledge_Express_Data_Systems Online information service for professionals in the bio-pharma and high-tech arenas. |
| LifeSensors_Inc__-_Cell_Based_Biosensors Utilizes innovations in human gene transcription technology to develop advanced ultrasensitive, high-throughput, cell-based biosensors. |
| Longenity_Inc_ Researching factors affecting longevity and therapies that prevent the detrimental effects associated with aging. |
| Lorantis,_Ltd_ Researching the mechanisms of immunosuppression and tolerance, to develop new medicines for immunological and inflammatory diseases. |
| LumiCyte,_Inc_ Provides biochips and information products. |
| MaxCyte Develops targeted drugs and non-viral gene delivery systems. Also, specialized in enhanced oxygen to cells treatments. |
| MediChem_Life_Sciences,_Inc_ Offers contract services in the fields of genomics, combinatorial chemistry and biopharmaceuticals. Lists company information and publications. |
| Meristem_Therapeutics Specializing in research and production of plant-derived recombinant therapeutic proteins. |
| Morphotek,_Inc_ Uses morphogenics to expedite the evolutions of organisms, such as plants and yeast, to obtain commercially useful output traits. |
| MWG_Biotech Products and services include molecular biology instruments, DNA sequencing, oligos, microarrays, and bioinformatics. |
| Nexgen_Biotech Develops and commercializes new recombinant proteins from transgenic plants. |
| Nexia_Biotechnologies Uses transgenetic goats milk to produce therapeutic proteins and biomaterials to treat serious diseases. Located in Canada. |
| Nordic_Bioscience_Diagnostics Develops immunodiagnostic products to identify diseases affecting bone and cartilage. |
| Novartis Created by the merger of Ciba and Sandoz. Has core businesses in healthcare, agribusiness and consumer health. |
| Novozymes_Biotech,_Inc_ Emphasizes research in identifying and engineering new industrial enzymes as well as improving the manufacturing process for new and existing enzymes. |
| Novozymes_com Creates bio-industrial products by using enzymes for such things as waste water cleanup, house cleaners and lawn maintenance. Provides contact information. |
| Orchid_BioSciences Develops products and services designed to measure and use in pharmacogenetics and drug discovery. |
| PCS_Process_Control_Systems_AG Solution provider for the automation of biotechnological and pharmaceutical processes. Based in Switzerland. |
| Pepscan_Systems Focused on the use of the knowledge of molecular recognition. |
| Phage_Biotech,_Ltd_ Presents a valid biological solution to the chemical antibiotics crisis. |
| Phycotransgenics_LLC Specializes in the development of transgenic microalgae to be used for animal health, animal feed, bioremediation, environmental monitoring and biopesticides. Includes information about the company |
| PinkCell_Laboratories An antibody developing company in the Netherlands, offering OEM products and antibody-developing services. Site includes details of products, services and positions vacant. |
| Plant_Research_International Offer research services in plant genetics and reproduction, crop physiology, agrosystems, soil fertility, and the optimization of plant health. |
| Precision_Therapeutics,_Inc_ Focusing on the interaction of cultivated tumor cells with chemotherapy and immunology-based drugs. |
| PrimeGen_Biotech_Corporation Specializes in stem cell research The purpose is to rejuvenate tissues in the body by replacing them with undifferentiated germ cells. Lists news releases relating to the company and contact informa |
| Prionics_AG Focused on developing diagnostic tests for prion diseases, and other neurological disorders. |
| Procorde_GmbH Biotechnology research in heart disease. |
| Prometic_-_Life_Science,_Inc_ Targets bioseparation and medical applications with its platform technologies, exploiting its proprietary synthetic ligands designed to effect very specific interactions with proteins. |
| Protéus Discovers biomolecules for large global markets. |
Home
| Policy
| Portfolio
| Profiles
| Pipeline|
Products
|Heber
Biotec | Patents|
News
|Search |
Our
goal
The
BUSINESS DEVELOPMENT GROUP (GNDP), created within the CENTER
FOR GENETIC ENGINEERING AND BIOTECHNOLOGY (CIGB) , Havana, Cuba, has
the mission to speed-up its Portfolio of R&D projects through alliances
with potential partners, under different business structures, thereby
allowing to complete the idea-product cycle and to continue developing
new biotechnology products.
Latest
press release
Havana - April 27. Neisseria vaccines expert meeting in Cuba to asses
the state of the art of meningococcal vaccines
Partnering
Opportunity
Each
project will be the subject of a separate negotiation.
After
statement of willingness of a potential partner to start discussions;
a secrecy agreement will be signed and then additional information
could be disclosed about the product.
A
negotiation team will be set up in order to discuss in detail the
status of the technology, the patent situation, the financial requirements,
the competition, the market estimations, the time schedule and the
risks.
In
general, the partner will share development costs according to a structure
of up-front fees, R&D funding and milestone payments to be discussed,
and will receive in exchange marketing rights for a given territory
and period of time.
Neither
equity purchase nor sharing of Cuban tangible asset property will
be included in the agreement.
xcept
for the above-mentioned statement, negotiations should be flexible
and innovative enough to accommodate very diverse business structures.
Video
CIGB
